Skip to main content
. Author manuscript; available in PMC: 2017 Mar 11.
Published in final edited form as: Neurosci Lett. 2016 Jan 29;616:80–85. doi: 10.1016/j.neulet.2016.01.057

Fig. 4.

Fig. 4

Effect of intra-VTA pilocarpine (0, 3, 30 μg/side) on FST, EPM, and locomotor activity. Pilocarpine increased immobility time in the FST (A), decreased time spent on the open arms of EPM (B), and had no effect on locomotor activity (C). Data expressed as mean ± S.E.M.; (* p < 0.05, ** p < 0.01, *** p < 0.001).